uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Vynfinit
Application withdrawn
Human
Details
EMA number
EMEA/H/C/002571
ATC code
L01
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of platinum resistant ovarian cancer (PROC)
MeSH:
Ovarian Neoplasms
Marketing Authorisation Holder
Endocyte Europe, B.V.
MAH
Vynfinit | uMedical